NCT05492227View on ClinicalTrials.gov

SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study

CompletedOBSERVATIONAL
Enrollment

607

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
COVID-19Coronavirus Disease 2019COVID-19 PandemicDiagnoses Disease
Interventions
DIAGNOSTIC_TEST

Left-overs

Totally nasal swab leftovers were stored from the biobank of Hospital Puerta del Hierro. The coded specimens were kept at -80°C and analyzed using the SARS-CoV-2 NAD Kit. Previously these specimens were analyzed using the gold-standard RT-PCR.

Trial Locations (1)

28222

Biobanco del Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

All Listed Sponsors
lead

TransGen Biotech Co., LTD

INDUSTRY